Repligen 

$132.57
31
+$1.98+1.52% 今天

統計

當日最高
134.72
當日最低
130.73
52週高點
175.77
52週低點
100.99
成交量
19,194,860
平均成交量
-
市值
7.47B
本益比
134.76
股息殖利率
-
股息
-

即將到來

財報

4Aug預期
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
下一步
0.34
0.38
0.43
0.48
預期EPS
0.453312
實際EPS
不適用

財務

6.62%利潤率
有盈利
2020
2021
2022
2023
2024
2025
1.48B營收
97.79M淨利

分析師評級

165.80平均目標價
最高預估為 208.00。
來自過去6個月內的 10 則評分。這不是投資建議。
買入
90%
持有
10%
賣出
0%

其他人也在關注

此清單是根據在 Stock Events 上追蹤 RGEN 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Repligen Corporation specializes in the creation and distribution of advanced bioprocessing technologies and integrated systems. These solutions are vital for various stages of biological drug production, serving clients across North America, Europe, the Asia Pacific region, and other international markets. The company's diverse product portfolio includes crucial components for biomanufacturing. This encompasses Protein A ligands, which serve as the key binding elements within Protein A affinity chromatography resins, as well as specialized cell culture growth factors. In the realm of chromatography, Repligen offers a range of products: Its OPUS line features pre-packed chromatography columns, instrumental in purifying biologics, alongside smaller-scale OPUS columns designed for high-throughput process development screening, viral clearance validation studies, and the scaling-down of chromatography processes. Additionally, the company supplies ELISA test kits and chromatography resins marketed under the CaptivA brand. Repligen also boasts an extensive suite of filtration products. This includes XCell Alternating Tangential Flow systems, which are filtration devices utilized in upstream perfusion and cell culture processing. For downstream applications like biologic drug concentration and formulation, they provide TangenX flat sheet cassettes. Other filtration offerings encompass KrosFlo tangential flow filtration and tangential flow depth filtration systems, Spectra/Por laboratory and process dialysis products, SpectraFlo dynamic dialysis systems, and ProConnex single-use hollow fibers. Furthermore, Repligen addresses process analytics with its slope spectroscopy systems, branded as SoloVPE, FlowVPE, and FlowVPX. Their clientele is broad, consisting of life sciences organizations, biopharmaceutical and diagnostics companies, laboratory researchers, and contract manufacturing organizations. Repligen also collaborates with partners, such as Navigo Proteins GmbH, on the development of various affinity ligands. The corporation was founded in 1981 and maintains its corporate headquarters in Waltham, Massachusetts.
Show more...
執行長
Mr. Olivier Loeillot
員工
1778
國家
美國
ISIN
US7599161095

上市

0 Comments

分享你的想法

FAQ

Repligen 今天的股價是多少?
RGEN 目前價格為 $132.57 USD,過去 24 小時上漲了 +1.52%。在圖表上更密切關注 Repligen 股價表現。
Repligen 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Repligen 的股票以代號 RGEN 進行交易。
Repligen 的股價在上漲嗎?
RGEN 股票較上週上漲 +6.07%,本月上漲 +29.23%,過去一年 Repligen 上漲 +4.25%。
Repligen 的市值是多少?
今天 Repligen 的市值為 7.47B
Repligen 下一次財報日期是什麼時候?
Repligen 將於 August 04, 2026 公布下一次財報。
Repligen 上一季度的財報如何?
RGEN 上一季度的財報為每股 0.48 USD,預估為 0.38 USD,帶來 +24.97% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Repligen 去年的營收是多少?
Repligen 去年的營收為 1.48BUSD。
Repligen 去年的淨利是多少?
RGEN 去年的淨收益為 97.79MUSD。
Repligen 有多少名員工?
截至 June 15, 2026,公司共有 1,778 名員工。
Repligen 位於哪個產業?
Repligen從事於Health & Wellness產業。
Repligen 何時完成拆股?
Repligen 最近沒有進行任何拆股。
Repligen 的總部在哪裡?
Repligen 的總部位於 美國 的 Waltham。